These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 17591062

  • 21. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.
    Nohara H, Okayama N, Inoue N, Koike Y, Fujimura K, Suehiro Y, Hamanaka Y, Higaki S, Yanai H, Yoshida T, Hibi T, Okita K, Hinoda Y.
    J Gastroenterol; 2004; 39(3):242-6. PubMed ID: 15065001
    [Abstract] [Full Text] [Related]

  • 22. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata.
    Shimizu T, Hizawa N, Honda A, Zhao Y, Abe R, Watanabe H, Nishihira J, Nishimura M, Shimizu H.
    Genes Immun; 2005 Jun; 6(4):285-9. PubMed ID: 15815686
    [Abstract] [Full Text] [Related]

  • 23. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L, Pfennig S, Haller D, Griga T, Klein W, Epplen JT, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Mussack T, Folwaczny M, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [Abstract] [Full Text] [Related]

  • 24. The G2964A polymorphism of the STAT6 gene in inflammatory bowel disease.
    Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Schmiegel W, Griga T.
    Dig Liver Dis; 2005 Mar; 37(3):159-61. PubMed ID: 15888279
    [Abstract] [Full Text] [Related]

  • 25. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
    Borm ME, van Bodegraven AA, Mulder CJ, Kraal G, Bouma G.
    Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
    [Abstract] [Full Text] [Related]

  • 26. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
    Amoli MM, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA.
    J Rheumatol; 2005 Jan; 32(1):74-6. PubMed ID: 15630728
    [Abstract] [Full Text] [Related]

  • 27. Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.
    Przybyłowska K, Mrowicki J, Sygut A, Narbutt P, Dziki Ł, Dziki A, Majsterek I.
    Pol Przegl Chir; 2011 Feb; 83(2):76-80. PubMed ID: 22166284
    [Abstract] [Full Text] [Related]

  • 28. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
    Tedde A, Laura Putignano A, Bagnoli S, Congregati C, Milla M, Sorbi S, Genuardi M, Papi L.
    Scand J Gastroenterol; 2008 Feb; 43(6):712-8. PubMed ID: 18569989
    [Abstract] [Full Text] [Related]

  • 29. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
    Haas SL, Andreas Koch W, Schreiber S, Reinhard I, Koyama N, Singer MV, Böcker U.
    Scand J Gastroenterol; 2005 Dec; 40(12):1438-43. PubMed ID: 16316892
    [Abstract] [Full Text] [Related]

  • 30. Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease.
    Torres OA, Calzada JE, Beraún Y, Morillo CA, González CI, González A, Martín J.
    Hum Immunol; 2009 Jul; 70(7):543-6. PubMed ID: 19376177
    [Abstract] [Full Text] [Related]

  • 31. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan.
    Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H, Hayashi R, Saito T, Yamada M, Fukuyama T, Otsuka T, Yano H, Ozaki K, Tsuchishima M, Tsutsumi M, Arisawa T.
    Cytokine; 2010 Aug; 51(2):173-7. PubMed ID: 20621719
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
    Radstake TR, Sweep FC, Welsing P, Franke B, Vermeulen SH, Geurts-Moespot A, Calandra T, Donn R, van Riel PL.
    Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects.
    Zhang H, Ma L, Dong LQ, Shu C, Xu JL.
    Gene; 2013 Sep 10; 526(2):228-31. PubMed ID: 23707797
    [Abstract] [Full Text] [Related]

  • 36. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.
    Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL.
    World J Gastroenterol; 2013 Oct 21; 19(39):6656-64. PubMed ID: 24151396
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
    Saibeni S, Spina L, Virgilio T, Folcioni A, Borsi G, de Franchis R, Cugno M, Vecchi M.
    Eur J Gastroenterol Hepatol; 2007 Nov 21; 19(11):976-81. PubMed ID: 18049167
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.